Europe Deep Brain Stimulation Devices Market Size & Outlook
Europe deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
Europe deep brain stimulation devices market highlights
- The Europe deep brain stimulation devices market generated a revenue of USD 297.5 million in 2024.
- The market is expected to grow at a CAGR of 10.8% from 2025 to 2030.
- In terms of segment, dystonia was the largest revenue generating application in 2024.
- Epilepsy is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Sweden is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 297.5 million |
| Market revenue in 2030 | USD 545.6 million |
| Growth rate | 10.8% (CAGR from 2025 to 2030) |
| Largest segment | Dystonia |
| Fastest growing segment | Epilepsy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 21.2% of the global deep brain stimulation devices market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 366.5 million by 2030.
Dystonia was the largest segment with a revenue share of 72.2% in 2024. Horizon Databook has segmented the Europe deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Europe follows North America in terms of share of deep brain stimulation devices market. Presence of well-established medical centers providing deep brain stimulation therapy is a high-impact rendering driver for growth in this region.
High cost associated with conventional treatments for neurological diseases is anticipated to drive the clinical urgency for cost-effective and long-term solutions such as deep brain stimulation devices therapy.
Increasing number of patients suffering from epilepsy, PD, and depression is expected to boost the demand for deep brain stimulation devices. In addition, increase in the number of government funded research projects, such as IMPACT, to promote awareness and improve quality of patients’ lives is anticipated to fuel the growth of deep brain stimulation devices market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe deep brain stimulation devices market size, by country, 2018-2030 (US$M)
Europe Deep Brain Stimulation Devices Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
